Data suggests Alzheimer's drug may benefit some patients

Data suggests Alzheimer's drug may benefit some patients
Save 30% On Your Mammoth Nation Membership - https://bit.ly/mammothtt30
USE CODE: TT30
Mammoth Nation is a membership-based online shopping platform that features American owned and operated businesses, while also openly supporting America First candidates and causes.
We are proudly committed to providing our members with a marketplace featuring companies that share your values, with an emphasis on American & Veteran-owned and operated businesses.

Artic Blast Overview: Relief. Freedom. Release From Pain. In 54 Seconds. Get your life back...Without pills or surgery. Learn More: http://bvyml.bemobtrcks.com/go/76680f19-d7df-44c4-8fb1-1c018be05193

Keep Your Family Safe From Mosquitos Without Using Chemicals: http://bvyml.bemobtrcks.com/go/c696e3db-781e-4543-b2e1-23e4e4b03b6a

Be one of the first to receive the debut presidential-edition 2024: The Revenge Tour watch (not available in stores!) GO HERE TO CLAIM: http://bvyml.bemobtrcks.com/go/bf6bf902-cdb2-4db8-bd7c-42adaa0b416f

Clinical trials of a new Alzheimer's drug, lecanemab, dropped Tuesday evening, indicating that it had demonstrated positive results in treating the condition.
"Lecanemab reduced markers of amyloid in early Alzheimer's disease and resulted in moderately less decline on measures of cognition and function than placebo at 18 months but was associated with adverse events," reads a summary of the report published in the New England Journal of Medicine. "Longer trials are warranted to determine the efficacy and safety of lecanemab in early Alzheimer's disease."
Manufacturer Eisai and Biogen announced in September that the trials had shown positive results, prompting a...
Source: https://justthenews.com/politics-policy/health/data-suggests-alzheimers-drug-may-benefit-some-patients?utm_source=justthenews.com&utm_medium=feed&utm_campaign=external-news-aggregators